Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2017172679) VIABLE CELL COMPOSITIONS, AND METHODS RELATED TO SAME
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2017/172679 International Application No.: PCT/US2017/024411
Publication Date: 05.10.2017 International Filing Date: 28.03.2017
IPC:
A01N 1/02 (2006.01)
A HUMAN NECESSITIES
01
AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
N
PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
1
Preservation of bodies of humans or animals, or parts thereof
02
Preservation of living parts
Applicants:
COOK GENERAL BIOTECHNOLOGY LLC [US/US]; 1102 Indiana Avenue Indianapolis, IN 46202, US
Inventors:
ZACHARIAS, Shelly, J.; US
WOODS, Erik, J.; US
Agent:
GANDY, Kenneth, A.; US
MORIARTY, John, V.; US
MCNETT, John, C.; US
HENRY, Thomas, Q.; US
REEVES, Charles, R.; US
Priority Data:
62/314,31628.03.2016US
Title (EN) VIABLE CELL COMPOSITIONS, AND METHODS RELATED TO SAME
(FR) COMPOSITIONS DE CELLULES VIABLES ET PROCÉDÉS ASSOCIÉS
Abstract:
(EN) Disclosed are viable cell compositions and related methods of preparation, maintenance and use. The viable cell composition can contain specified levels of cells, hydroxy ethyl starch, and dimethylsulf oxide, and can be cryopreserved. The cryopreserved form of the composition can be thawed and combined with an aqueous liquid diluting medium to prepare a diluted viable cell composition that can contain specified, reduced levels of the dimethylsulfoxide and hydroxyethyl starch. The diluting medium can contain trehalose. The prepared, diluted viable cell composition can be administered to a patient.
(FR) L'invention concerne des compositions de cellules viables et des procédés associés de préparation, de préservation et d'utilisation. La composition de cellules viables peut contenir des niveaux déterminés de cellules, d'hydroxyéthylamidon et de diméthylsulfoxyde, et peut être cryoconservée. La forme cryoconservée de la composition peut être décongelée et combinée avec un milieu de dilution liquide aqueux pour préparer une composition de cellules viables diluée qui peut contenir des niveaux réduits déterminés de diméthylsulfoxyde et d'hydroxyéthylamidon. Le milieu de dilution peut contenir du tréhalose. La composition de cellules viables diluée préparée peut être administrée à un patient.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)